IBX
Click for more information
2.38% 8.2¢ imagion biosystems limited

Ann: Imagion to complete the MagSense HER2 Phase 1 Study, page-4

  1. Paulk22
    264 Posts.
    lightbulb Created with Sketch. 70
    clock Created with Sketch.
    21/06/23
    08:50
    Post #: 68391043
    In March 2023 the Company received feedback from the FDA pertaining to its clinical development plans and intent to proceed with a mul-site Phase 2 study in the U.S. The Phase 2 study will be used to opmize dose and imaging schedules as well as explore various endpoints for clinical validity.
    IBX Price at posting: 1.2¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 15  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
8.2¢ 		Change
-0.002(2.38%) 		Mkt cap ! $2.677M
Open High Low Value Volume
8.2¢ 8.2¢ 8.2¢ $1.456K 17.76K

Buyers (Bids)

No. Vol. Price($)
1 12240 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.6¢ 750 1
View Market Depth
Last trade - 15.14pm 03/07/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.